Comparing outcomes and costs among warfarin-sensitive patients versus warfarin-insensitive patients using The Right Drug, Right Dose, Right Time: Using genomic data to individualize treatment (RIGHT) 10K warfarin cohort

Oral anticoagulant (OAC) therapy has been the main treatment approach for stroke prevention for decades. Warfarin is the most widely prescribed OAC in the United States, but is difficult to manage due to variability in dose requirements across individuals. Pharmacogenomics may mitigate risk concerns...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:PLoS One
Main Authors: Swanson, Kristi M., Zhu, Ye, Rojas, Ricardo L., St. Sauver, Jennifer L., Bielinski, Suzette J., Jacobsen, Debra J., Visscher, Sue L., Wang, Liewei, Weinshilboum, Richard, Borah, Bijan J.
Formato: Artigo
Idioma:Inglês
Publicado em: Public Library of Science 2020
Assuntos:
Research Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC7237006/
https://ncbi.nlm.nih.gov/pubmed/32428022
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1371/journal.pone.0233316
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados